MedTrace Logo

Effect of Adjunctive Intracoronary Streptokinase on Late Term Left Ventricular Infarct Size and Volumes in Patients With Acute Myocardial Infarction

NCT00627809 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2009-06-23

No results posted yet for this study

Summary

The investigators hypothesized that complementary intracoronary streptokinase administration to primary percutaneous intervention in patients with acute myocardial infarction may provide limitation infarct size and improvement in left ventricular volumes and function in acute and late phases (6 months).

Conditions

  • Acute Coronary Syndromes
  • Acute Myocardial Infarction
  • Reperfusion Injury

Interventions

DRUG

Streptokinase

intracoronary infusion, 250.000 Units

PROCEDURE

primary percutaneous coronary intervention

balloon catheter, stent

Sponsors & Collaborators

  • Istanbul University

    lead OTHER

Principal Investigators

  • Murat Sezer, Assoc. Prof. · Istanbul University, Istanbul Faculty of Medicine, Department of Cardiology

  • Sabahattin Umman, Prof. · Istanbul University,Istanbul Faculty of Medicine, Department of Cardiology

  • Arif O Cimen, M.D. · Istanbul University, Istanbul Faculty of Medicine, Department of Cardiology

  • Emre K Aslanger, M.D. · Istanbul University, Istanbul Faculty of Medicine, Department of Cardiology

  • Berrin Umman, Prof. · Istanbul University, Istanbul Faculty of Medicine, Department of Cardiology

  • Zehra Bugra, Prof. · Istanbul University, Istanbul Faculty of Medicine, Department of Cardiology

  • Isik Adalet, Prof. · Istanbul University, Istanbul Faculty of Medicine, Department of Nuclear Medicine

  • Cuneyt Turkmen, Assoc. Prof. · Istanbul University, Istanbul Faculty of Medicine, Department of Nuclear Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2008-01-31
Completion
2008-02-29

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00627809 on ClinicalTrials.gov